Cardiac Rehabilitation Is One of Cardiology’s Most Underused Interventions. This Conference Is Working to Change That.
At the end of September, over a thousand cardiovascular and pulmonary professionals will gather in San Antonio for the 41st AACVPR Annual Meeting, the premier event for the American Association of Cardiovascular and Pulmonary Rehabilitation. The three-day conference brings together physicians, exercise physiologists, respiratory therapists, cardiovascular nurses, behavioral scientists, and registered dietitians working across the full continuum of cardiac and pulmonary recovery. For Dr. Christopher Mallavarapu, whose clinical practice spans heart failure management, coronary artery disease treatment, and post-intervention care across multiple hospital affiliations, the conversation happening in San Antonio is one that deserves far more attention than it typically gets.
The Problem With Cardiac Rehab Is Not the Evidence
Cardiac rehabilitation is a Class I recommendation in international cardiovascular guidelines — the highest possible designation, meaning the evidence in its favor is overwhelming and the indication is well-established. It reduces morbidity, lowers the risk of readmission, improves functional capacity, and extends life after acute cardiac events including heart attacks, bypass surgery, heart failure, and interventional procedures. The evidence is not the problem. The problem is utilization. Despite those guidelines, referral rates for cardiac rehab fail to reach even 25% among Medicare beneficiaries, according to the American College of Cardiology — a gap that represents a significant missed opportunity to improve patient outcomes and reduce costs.
Why Patients Are Not Getting There
The barriers are not uniform, but they are consistent. Access is a meaningful obstacle, particularly for patients in rural or underserved communities where cardiac rehab programs are sparse or nonexistent. Transportation, work schedules, cost, and the absence of a direct physician referral all contribute. Research shows that 91% of patients globally do not complete more than half of their advised rehab sessions — and in the post-TAVR population specifically, only 30.6% of eligible patients initiated cardiac rehabilitation within 90 days of discharge. For a Class I intervention, that number reflects a systemic failure of follow-through, not a failure of the therapy itself.
What Telerehabilitation Is Changing
One of the more encouraging developments in this space is the evidence building around hybrid and telerehabilitation models. A 2025 randomized trial demonstrated that a hybrid cardiac rehab model — combining in-person and remote sessions — produced comparable improvements in functional capacity, strength, and cardiopulmonary performance compared to traditional center-based programs, with nearly 70% adherence and high patient satisfaction. For patients who cannot reach a facility regularly, that data matters. It opens a realistic path to accessing a proven intervention that geography or circumstance would otherwise put out of reach.
Why This Matters for Patients in Olean and Northern Maine
Dr. Christopher Mallavarapu sees cardiac rehabilitation as a critical and underused component of complete cardiovascular care. In regional communities like Olean and Fort Kent — where patients may face longer distances to specialized facilities — the gap between what cardiac rehab can do and what patients actually receive is especially pronounced. Closing that gap starts with awareness and consistent referral. What AACVPR 2026 brings to that conversation is the evidence, the clinical community, and the practical frameworks that make better implementation possible.